Spero Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Spero Therapeutics Inc
TickerSPRO
CIK #0001701108
CUSIP83171G103
SectorLife Sciences - Pharmaceutical Preparations
Address675 Massachusetts Avenue 14th Floor, Cambridge, MA 02139
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Spero Therapeutics Inc 2022-11-15 9.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
Spero Therapeutics LLC 2017-03-21 43.2 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001701108] 10-K
[0001701108] 10-Q
[0001701108] 3
[0001701108] 4
[0001701108] 8-K
[0001701108] D
[0001701108] SC 13D
[0001701108] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Anson Funds Management LP Spero Therapeutics Inc [2024-02-14] 81948.1
BlackRock Inc Spero Therapeutics Inc [2022-07-08] 2.1
Pfizer Inc Spero Therapeutics Inc [2021-07-09] 7.37
BlackRock Inc Spero Therapeutics Inc [2021-02-02] 6.4
Atlas Venture Fund X LP Spero Therapeutics Inc [2018-03-14] 7.2
RA Capital Management LLC Spero Therapeutics Inc [2018-02-14] 8.5
Lundbeckfond Invest A/S Spero Therapeutics Inc [2018-02-14] 7.6
GV 2015 LP Spero Therapeutics Inc [2018-02-14] 7.7
Atlas Venture Associates IX LP Spero Therapeutics Inc [2018-02-13] 0.58
FMR LLC Spero Therapeutics Inc [2018-02-13] 0.0
GlaxoSmithKline PLC Spero Therapeutics Inc [2017-11-16] 13.3
Merck & Co Inc Spero Therapeutics Inc [2017-11-15] 6.5
Biotechnology Value Fund L P Spero Therapeutics Inc [2017-11-09] 3.7
Form 3/4/5 Filer 2011 - 2026
Jackson Scott Thomas
Spero Therapeutics Inc
Pottage John C Jr
Deshpande Milind
Tregoning Kathleen
Smith Cynthia
VINK Patrick VJJ
Thomas Frank E
Rajavelu Esther
Keutzer Timothy
Mahadevia Ankit
Shukla Sath
Hamed Kamal
Joseph Tamara L
DiPalma Stephen J
GlaxoSmithKline PLC
Aquilo Capital LP
Aquilo Capital Management LLC
Melnick David A
Larkin Cristina
Formela Jean Francois
Sendek Joel
Parr Thomas R JR
Southwell David P
Breum Casper
Goyal Vikas
Atlas Venture Fund IX LP
Atlas Venture Associates IX LP
Atlas Venture Associates IX LLC
GV 2015 LP
Alphabet Inc
GV 2015 GP LLC
Halse Reza
Lundbeckfond Invest A/S
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Rajavelu Esther
Common Stock
2026-02-06 Sell 37,101 $2.36 87,558
Keutzer Timothy
Common Stock
2026-02-06 Sell 18,652 $2.36 44,019
Rajavelu Esther
Common Stock
2026-02-06 Sell 50,816 $2.36 119,926
Keutzer Timothy
Common Stock
2026-02-04 Sell 3,471 $2.24 7,775
Keutzer Timothy
Common Stock
2026-02-03 Sell 24,224 $2.14 51,839
Rajavelu Esther
Stock Option (Right to Buy) · derivative
2026-02-02 Grant 498,000 $0.00
Rajavelu Esther
Common Stock
2026-02-02 Sell 18,442 $2.20 40,572
Keutzer Timothy
Common Stock
2026-02-02 Sell 18,891 $2.20 41,560
Keutzer Timothy
Common Stock
2026-02-02 Grant 68,000 $0.00
Rajavelu Esther
Common Stock
2026-02-02 Grant 249,000 $0.00
Keutzer Timothy
Stock Option (Right to Buy) · derivative
2026-02-02 Grant 137,000 $0.00
Rajavelu Esther
Common Stock
2025-11-07 Sell 40,270 $2.37 95,440
Common Stock
2025-08-28 Sell 6,572 $1.97 12,947
Common Stock
2025-08-28 Sell 1,695 $1.97 3,339
Pottage John C Jr
Common Stock
2025-06-12 Grant 20,000 $0.00
Mahadevia Ankit
Common Stock
2025-06-12 Grant 20,000 $0.00
Deshpande Milind
Common Stock
2025-06-12 Grant 20,000 $0.00
Jackson Scott Thomas
Common Stock
2025-06-12 Grant 20,000 $0.00
VINK Patrick VJJ
Common Stock
2025-06-12 Grant 20,000 $0.00
Smith Cynthia
Common Stock
2025-06-12 Grant 20,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 50 21,233,902
2025-12-31 56 21,225,804
2025-09-30 49 11,372,142
2025-06-30 44 11,270,053
2025-03-31 40 15,117,816
2024-12-31 51 16,055,503
2024-09-30 47 12,344,390
2024-06-30 49 13,878,715
2024-03-31 56 13,792,646
2023-12-31 51 13,847,187
2023-09-30 54 14,170,585
2023-06-30 57 14,363,822
Form 13F Holdings
Firm Period DFND Voting Shares
DLK Investment Management LLC [2026-06-30] SOLE 31,355 31,355
Assenagon Asset Management SA [2026-06-30] SOLE 18,636 18,636
FNY Investment Advisers LLC [2026-06-30] SOLE 8,300 10
Farther Finance Advisors LLC [2026-06-30] SOLE 0 10
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com